134 related articles for article (PubMed ID: 22541650)
1. Enhanced circulating soluble LR11 in patients with diabetic retinopathy.
Takahashi M; Bujo H; Shiba T; Jiang M; Maeno T; Shirai K
Am J Ophthalmol; 2012 Jul; 154(1):187-92. PubMed ID: 22541650
[TBL] [Abstract][Full Text] [Related]
2. Circulating soluble form of LR11, a regulator of smooth muscle cell migration, is a novel marker for intima-media thickness of carotid arteries in type 2 diabetes.
Jin W; Jiang M; Han X; Han X; Murano T; Hiruta N; Ebinuma H; Piao L; Schneider WJ; Bujo H
Clin Chim Acta; 2016 Jun; 457():137-41. PubMed ID: 27095609
[TBL] [Abstract][Full Text] [Related]
3. Vitreous fluid and circulating levels of soluble lr11, a novel marker for progression of diabetic retinopathy.
Shiba T; Bujo H; Takahashi M; Sato Y; Jiang M; Hori Y; Maeno T; Shirai K
Graefes Arch Clin Exp Ophthalmol; 2013 Dec; 251(12):2689-95. PubMed ID: 23652469
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of measuring soluble LR11, a circulating marker of atherosclerosis and HbA1c in familial hypercholesterolemia.
Nohara A; Kobayashi J; Kawashiri MA; Tada H; Inazu A; Jiang M; Mabuchi H; Bujo H
Clin Biochem; 2014 Sep; 47(13-14):1326-8. PubMed ID: 24859021
[TBL] [Abstract][Full Text] [Related]
5. Enhanced circulating soluble LR11 in patients with coronary organic stenosis.
Takahashi M; Bujo H; Jiang M; Noike H; Saito Y; Shirai K
Atherosclerosis; 2010 Jun; 210(2):581-4. PubMed ID: 20047743
[TBL] [Abstract][Full Text] [Related]
6. Levels of the soluble LDL receptor-relative LR11 decrease in overweight individuals with type 2 diabetes upon diet-induced weight loss.
Berk KA; Vongpromek R; Jiang M; Schneider WJ; Timman R; Verhoeven AJ; Bujo H; Sijbrands EJ; Mulder MT
Atherosclerosis; 2016 Nov; 254():67-72. PubMed ID: 27697674
[TBL] [Abstract][Full Text] [Related]
7. Circulating LR11 is a novel soluble-receptor marker for early-stage clinical conditions in patients with non-Hodgkin's lymphoma.
Fujimura K; Ebinuma H; Fukamachi I; Ohwada C; Kawaguchi T; Shimizu N; Takeuchi M; Sakaida E; Jiang M; Nakaseko C; Bujo H
Clin Chim Acta; 2014 Mar; 430():48-54. PubMed ID: 24394293
[TBL] [Abstract][Full Text] [Related]
8. Increased circulating soluble LR11 in patients with acute coronary syndrome.
Ogita M; Miyauchi K; Dohi T; Tsuboi S; Miyazaki T; Yokoyama T; Yokoyama K; Shimada K; Kurata T; Jiang M; Bujo H; Daida H
Clin Chim Acta; 2013 Jan; 415():191-4. PubMed ID: 23127357
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of circulating soluble LR11 on long-term clinical outcomes in patients with coronary artery disease.
Ogita M; Miyauchi K; Kasai T; Tsuboi S; Wada H; Naito R; Konishi H; Dohi T; Tamura H; Okazaki S; Yanagisawa N; Shimada K; Suwa S; Jiang M; Bujo H; Daida H
Atherosclerosis; 2016 Jan; 244():216-21. PubMed ID: 26687467
[TBL] [Abstract][Full Text] [Related]
10. Development of an immunoassay for the quantification of soluble LR11, a circulating marker of atherosclerosis.
Matsuo M; Ebinuma H; Fukamachi I; Jiang M; Bujo H; Saito Y
Clin Chem; 2009 Oct; 55(10):1801-8. PubMed ID: 19661140
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of serum soluble LR11 in newly diagnosed diffuse large B-cell lymphoma: A multicenter prospective analysis.
Sugita Y; Ohwada C; Kawaguchi T; Muto T; Tsukamoto S; Takeda Y; Mimura N; Takeuchi M; Sakaida E; Shimizu N; Tanaka H; Abe D; Fukazawa M; Sugawara T; Aotsuka N; Nishiwaki K; Shono K; Ebinuma H; Fujimura K; Bujo H; Yokote K; Nakaseko C
Clin Chim Acta; 2016 Dec; 463():47-52. PubMed ID: 27725222
[TBL] [Abstract][Full Text] [Related]
12. Circulating soluble LR11, a differentiation regulator for vascular cells, is increased during pregnancy and exaggerated in patients with pre-eclampsia.
Ishida H; Jiang M; Ebinuma H; Hiruta N; Schneider WJ; Kinoshita T; Bujo H
Clin Chim Acta; 2019 Oct; 497():172-177. PubMed ID: 31299181
[TBL] [Abstract][Full Text] [Related]
13. LR11/SorLA links triglyceride-rich lipoproteins to risk of developing cardiovascular disease in FH patients.
Vongpromek R; Bujo H; Hoekstra M; Schneider WJ; van der Zee L; Schinkel AF; Korporaal SJ; Dik WA; Ebinuma H; Jiang M; Verhoeven AJ; Sijbrands EJ; Mulder MT
Atherosclerosis; 2015 Dec; 243(2):429-37. PubMed ID: 26520897
[TBL] [Abstract][Full Text] [Related]
14. Soluble form of LR11 is highly increased in the vitreous fluids of patients with idiopathic epiretinal membrane.
Hashimoto R; Jiang M; Shiba T; Hiruta N; Takahashi M; Higashi M; Hori Y; Bujo H; Maeno T
Graefes Arch Clin Exp Ophthalmol; 2017 May; 255(5):885-891. PubMed ID: 28102455
[TBL] [Abstract][Full Text] [Related]
15. Circulating soluble LR11/SorLA levels are highly increased and ameliorated by chemotherapy in acute leukemias.
Sakai S; Nakaseko C; Takeuchi M; Ohwada C; Shimizu N; Tsukamoto S; Kawaguchi T; Jiang M; Sato Y; Ebinuma H; Yokote K; Iwama A; Fukamachi I; Schneider WJ; Saito Y; Bujo H
Clin Chim Acta; 2012 Oct; 413(19-20):1542-8. PubMed ID: 22750733
[TBL] [Abstract][Full Text] [Related]
16. Serum cortisol is a biomolecular biomarker for severity of diabetic retinopathy.
Mohan A; Saxena S; Kaur A; Ali W; Akduman L
Mol Vis; 2021; 27():429-437. PubMed ID: 34267498
[TBL] [Abstract][Full Text] [Related]
17. Levels of circulating soluble LR11, a regulator of smooth muscle cell migration, are highly associated with atherosclerotic plaques in patients with carotid artery stenosis.
Harada M; Jiang M; Terai K; Ebinuma H; Hiruta N; Schneider WJ; Sugo N; Nagao T; Bujo H
Clin Chim Acta; 2019 Mar; 490():69-76. PubMed ID: 30550937
[TBL] [Abstract][Full Text] [Related]
18. Serum erythropoietin concentration and its correlation with stage of diabetic retinopathy.
Davidović S; Babić N; Jovanović S; Barišić S; Grković D; Miljković A
BMC Ophthalmol; 2019 Nov; 19(1):227. PubMed ID: 31727007
[TBL] [Abstract][Full Text] [Related]
19. Circulating soluble LR11, a novel marker of smooth muscle cell proliferation, is enhanced after coronary stenting in response to vascular injury.
Ogita M; Miyauchi K; Jiang M; Kasai T; Tsuboi S; Naito R; Konishi H; Dohi T; Yokoyama T; Okazaki S; Shimada K; Bujo H; Daida H
Atherosclerosis; 2014 Nov; 237(1):374-8. PubMed ID: 25443876
[TBL] [Abstract][Full Text] [Related]
20. Pentosidine and N-carboxymethyl-lysine: biomarkers for type 2 diabetic retinopathy.
Ghanem AA; Elewa A; Arafa LF
Eur J Ophthalmol; 2011; 21(1):48-54. PubMed ID: 20544678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
